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A number of oxidoreductases from the VAO/para-cresol
methylhydroxylase flavoprotein family catalyze the oxidation of
para-substituted phenols. One of the best-studied is vanillyl-
alcohol oxidase (VAO) from the fungus Penicillium simplicissi-
mum. For oxidation of phenols by VAO to occur, theymust first
be bound in the active site of the enzyme in their phenolate
anion form. The crystal structure of VAO reveals that two tyro-
sine residues, Tyr-108 and Tyr-503, are positioned to facilitate
this deprotonation. To investigate their role in catalysis, we cre-
ated three VAO variants, Y108F, Y503F, and Y108F/Y503F, and
studied their biochemical properties. Steady-state kinetics indi-
cated that the presence of at least one of the tyrosine residues is
essential for efficient catalysis by VAO. Stopped-flow kinetics
revealed that the reduction of VAO by chavicol or vanillyl alco-
hol occurs at two different rates: kobs1, which corresponds to its
reaction with the deprotonated form of the substrate, and kobs2,
which corresponds to its reaction with the protonated form of
the substrate. In Y108F, Y503F, and Y108F/Y503F, the relative
contribution of kobs2 to the reduction is larger than in wild-type
VAO, suggesting deprotonation is impaired in these variants.
Binding studies disclosed that the competitive inhibitor
isoeugenol is predominantly in its deprotonated form when
bound to wild-type VAO, but predominantly in its protonated
form when bound to the variants. These results indicate that
Tyr-108 and Tyr-503 are responsible for the activation of sub-
strates in VAO, providing new insights into the catalytic mech-
anism of VAO and related enzymes that oxidize para-substi-
tuted phenols.
Vanillyl-alcohol oxidase (VAO)2 (EC 1.1.3.38) from Penicil-
lium simplicissimum is a flavin-dependent oxidase that cata-
lyzes the oxidation of para-substituted phenolic compounds
using molecular oxygen as an electron acceptor (1–3). It is a
64-kDa (560 amino acid) protein that forms octameric struc-
tures with each subunit containing an FAD cofactor that is
covalently linked to the protein via an 8-N3-histidyl-FAD
bond (4). VAO is amember of the VAO/para-cresol methylhy-
droxylase (PCMH) flavoprotein family, which consists of ho-
mologous oxidoreductases that catalyze a wide range of
reactions, but share a conserved FAD-binding domain (5).
Although VAO catalyzes a range of reactions, such as the oxi-
dation of benzylic alcohols to aldehydes, the oxidative deami-
nation of benzylic amines, the hydroxylation of 4-allylphenols,
and the hydroxylation or dehydrogenation of 4-alkylphenols, it
displays a strict selectivity toward the oxidation of para-substi-
tuted phenols at the C atom of their side chain. The proposed
catalytic mechanism of VAO provides an explanation for this
selectivity (Fig. 1A) (2, 6, 7). First, the substrates of VAO are
bound in the active site in their deprotonated phenolate form.
Subsequently, a hydride anion is transferred from the C atom
of the side chain of the substrate to the N5 atom of FAD, yield-
ing the reduced enzyme and a para-quinone methide interme-
diate. Finally, this intermediate either reacts with water or
rearranges to yield the product of the reaction, and FAD is
reoxidized by molecular oxygen, which is converted to hy-
drogen peroxide. The initial deprotonation of the phenolic
hydroxyl group of the substrate is likely a crucial step in this
mechanism, as it promotes the hydride-transfer reaction by
enabling the formation of the para-quinone methide interme-
diate. Studies using the competitive inhibitor isoeugenol (Fig.
1B) revealed that its pKa is lowered from10 to 5 uponbinding to
VAO (2). A potential explanation for this decrease is provided
by examining the crystal structure of VAO in complex with
isoeugenol (4). Three polar residues, Tyr-108, Tyr-503, and
Arg-504, form a phenolate-binding pocket, with their side
chains positioned within hydrogen bonding distance of pheno-
lic hydroxyl group of the isoeugenol (Fig. 2A). These residues
may facilitate deprotonation of the substrate either by promot-
ing preferential binding of the deprotonated form or by one of
the tyrosine residues acting as a base and actively deprotonating
the substrate in the active site. All three residues are conserved
in the homologous flavoenzymes eugenol oxidase (EUGO) and
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para-cresol methylhydroxylase (PCMH, EC 1.17.99.1), which
also catalyze the oxidation of para-substituted phenols (8, 9).
The role of Arg-474 in PCMH, which corresponds to Arg-504
in VAO, has been studied by site-directed mutagenesis and it
was found to be of importance in achieving covalent incorpo-
ration of the cofactor of the enzyme and in enabling efficient
catalysis by modulating the redox properties of both the cofac-
tor and enzyme-bound substrates (10). Here, we investigated
the role played by Tyr-108 and Tyr-503 in VAO using site-
directed mutagenesis. Three VAO variants, Y108F, Y503F, and
Y108F/Y503F, were created, expressed, and purified and their
catalytic properties were studied. Our results reveal that the
presence of at least one of these tyrosine residues is essential for
efficient catalysis.
Results
The Y108F, Y503F, and Y108F/Y503F variants were success-
fully expressed in Escherichia coli and purified. Like wild-type
(wt)-VAO, all three variants contained a covalently bound FAD
cofactor, as judged from the yellow pellet and colorless super-
natant obtained after precipitation of the proteins with trichlo-
roacetic acid. In their native form, all variants displayed an octa-
meric quaternary structure, as demonstrated by analytical
size exclusion chromatography (data not shown). The flavin
absorption spectra of the variants were highly similar to that of
wt-VAO (see spectral studies presented below), demonstrating
that the introducedmutations do not lead to anymajor changes
in the electronic environment of their flavin cofactor. To deter-
mine whether the introduced mutations affect the stability of
VAO, thermal midpoints of unfolding of the variants were
determined using the ThermoFAD method (11). This yielded
thermal midpoints of unfolding of 55 °C for wt-VAO, 53 °C for
Y108F and Y503F, and 52 °C for Y108F/Y503F, suggesting the
introduced mutations have a minor deleterious effect on the
thermostability of VAO.
Steady-state catalytic properties
To determine the effect of the introduced mutations on the
catalytic efficiency of VAO, we measured the apparent steady-
Figure 1. A, oxidation of vanillyl alcohol as catalyzed by VAO. First, the sub-
strate is bound in the active site in its deprotonated phenolate form. This
facilitates the transfer of a hydride anion from the C of the substrate to FAD,
yielding a para-quinonemethide intermediate and the reduced enzyme. This
intermediate subsequently rearranges to give the aldehyde product vanillin
and FAD is reoxidized by molecular oxygen, which is converted to hydrogen
peroxide. B, structures of chavicol and isoeugenol.
Figure 2. Structure of the phenolate-binding pocket of VAO in the wild-
type enzyme (A, carbon in white (PDB code 2VAO (4))) and in the Y108F
and Y503F variants (B and C, respectively, carbon in gray). The refined
2Fo Fc electron density map (contoured at 1.2) is shown for the mutated
residues Y108F and Y503F as blue chicken-wire. The wt-VAO crystal structure
in complex with the competitive inhibitor isoeugenol (A, carbon in green) is
taken as a reference to analyze the mutant proteins. As reported in Ref. 4,
binding of isoeugenol does not significantly influence the geometry of the
active site. In B and C, the side chains of Tyr-108 and Tyr-503, respectively,
from wt-VAO are shown for comparison. As described in the text, in the
Y503F mutant Phe-503 is slightly tilted with respect to the corresponding
Tyr-503 in wt-VAO. Tyr-108, Tyr-503, Arg-504, Ser-426, isoeugenol, and the
FAD cofactor (carbon in yellow) are displayed in stick representation with
the surrounding protein backbone shown in schematic representation.
Oxygen atoms are in red, nitrogen atoms in blue, and phosphorous atoms
in magenta. Potential hydrogen bonds are depicted as black dashed lines.
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state kinetic parameters for the oxidation of two substrates:
vanillyl alcohol, which is oxidized to the aldehyde vanillin, and
chavicol (Fig. 1B), which is hydroxylated to coumaryl alcohol.
The kinetic parameters for the oxidation of these substrates are
listed inTable 1. Interestingly, the effect of themutations varied
depending on the substrate.With vanillyl alcohol, the kcat drops
to2% of that of wt-VAO for both the Y108F and Y503F vari-
ants. With chavicol, a more minor drop in the kcat value to
45% of that of the wild-type enzyme was observed for the
Y108F and Y503F variants. With chavicol, the Y108F/Y503F
variant displayed a kcat value of less than 2% of that of wt-VAO
and with vanillyl alcohol, the activity was too low to accurately
determine kinetic parameters. This indicates that the presence
of at least one of the two tyrosine residues is essential for effec-
tive catalysis. For each variant, the Km increased for each sub-
strate. Themagnitude of the increase ranged from3- to 12-fold.
Stopped-flow kinetics of the reductive half-reaction
To determine whether the decreased catalytic efficiencies
observed for the VAO variants were due to impaired reduction
of their FAD cofactor, spectral changes during the anaerobic
reduction of the enzymes by vanillyl alcohol or chavicol were
followed by stopped-flow spectroscopy. Where possible, pho-
todiode array detection was used to monitor changes over a
spectral range from 254 to 725 nm. However, with long
measurement times (10 s), the high-intensity illumination
required for this led to photoreduction of FAD. Therefore, in
cases where the reduction reaction was slow, it was monitored
using single wavelength detection at 439 nm, the absorption
maximum of the oxidized FAD in VAO. This was the case for
the reduction of the Y108F and Y503F variants by 2mM vanillyl
alcohol and for all reactions involving theY108F/Y503F variant.
Observed rates for the anaerobic reduction of wt-VAO and
theY108F andY503F variants by 2mMvanillyl alcohol at pH6.2
and 7.5 are given in Table 2. The anaerobic reduction of wt-
VAO by vanillyl alcohol at pH 7.5 has been studied previously
and was found to be a biphasic process with rate constants
at saturating substrate concentrations of kred1  24 s1 and
kred2  3.5 s1 (6). The two different rates of reduction were
interpreted to be caused by the presence of two conformations
of the enzyme. The rate of the slower phase, kred2, lies close to
kcat and is rate-limiting for catalysis. Our results with wt-VAO
are in good agreement with these data. The effect of the Y108F
and Y503F mutations on the rate of reduction by vanillyl alco-
hol was similar. In each variant, the reduction was a biphasic
process. Each of the rates of reduction has dropped significantly
as compared with wt-VAO. The rates of the two phases are in
the same range and kobs2 is similar to the rate of steady-state
catalysis, suggesting that flavin reduction is rate-limiting in
these variants. In addition to the decrease in both reduction
rates, the relative contribution of the two kinetic events to the
drop in absorption at 439 nm (amplitude a) has changed. In
wt-VAO, kobs1 has a greater contribution than kobs2 (a1:a2 
2:1), whereas in the Y108F and Y503F variants, kobs2 has a
greater contribution than kobs1 (a1:a2  1:5 for Y108F and 1:3
for Y503F). At pH 6.2, reduction by vanillyl alcohol was also
biphasic for all variants. For wt-VAO, the rates of the two
phases are very similar to those at pH 7.5. However, their con-
tributions to the reduction have changed, with kobs2 having a
greater contribution than kobs1 (a1:a2 1:3). In the Y108F and
Y503F variants, kobs1 is somewhat higher than observed at pH
7.5 and kobs2 is slightly lower in Y108F and does not change
significantly in Y503F. As observed for wt-VAO, the contribu-
tion of the two rates to the change in absorption shifts, with
kobs2 becoming more predominant (a1:a2  1:32 for each
variant).
Spectra obtained during the anaerobic reduction of wt-VAO
by 100 M chavicol are shown in Fig. 3. After mixing wt-VAO
with chavicol, the characteristic peak of the oxidized flavin
cofactor of the enzyme (maximum at 439 nm) rapidly disap-
pears, indicating that FAD is reduced by the substrate. At the
same time, the absorption between 320 and 430 nm increases,
yielding an intense peak with a maximum at 373 nm. This peak
reaches its maximum intensity after 600 ms, after which it
decreases in intensity. The formation of a species with similar
spectral characteristics has been observed during the anaerobic
reduction of wt-VAO by vanillyl alcohol (max  362 nm) or
4-(methoxymethyl)phenol (max 364 nm) and was attributed
to a complex between the quinone methide intermediate and
the reduced enzyme formed after the electron-transfer reaction
Table 1
Apparent steady-state kinetic parameters for the oxidation of vanillyl
alcohol and chavicol by VAO variants
Kinetic parameters were determined at 25 °C in 50mMpotassium phosphate buffer,
pH 7.5.Ki is the inhibition constant for substrate inhibition, which was observed for
all variants when using chavicol as a substrate.
VAO variant kcat Km kcat/Km Ki
s1 M s1 mM1 mM
Vanillyl alcohol
Wild Type 2.6a 149a 17
Y108F 0.042 0.006 1750 420 0.024
Y503F 0.055 0.002 990 60 0.056
Y108F/Y503F NDb ND ND
Chavicol
Wild Type 7.4 0.1 6.5 0.3 1138 7.0 1.1
Y108F 3.4 0.1 67 7 51 2.9 0.4
Y503F 3.3 0.1 21 2 157 0.45 0.04
Y108F/Y503F 0.13 0.01 74 6 1.8 1.4 0.2
a Data were taken from Ref. 14.
b ND, not determined due to low reaction rate (observed rate0.01 s1 at 2 mM
vanillyl alcohol concentration).
Table 2
Observed rates of reduction of VAO variants by 2 mM vanillyl alcohol
Rates were determined by fitting appropriate exponential functions to single wave-
length traces of the absorption at 439 nm obtained after mixing 10M enzyme with
2 mM vanillyl alcohol in 50 mM potassium phosphate buffer, pH 6.2 or 7.5, under
anaerobic conditions at 25 °C using a stopped-flow apparatus. Values in parentheses
give the relative contribution of kobs1 and kobs2, the two phases associated with flavin
reduction, to the drop in absorption. The observed rates for the oxidation of 2 mM
vanillyl alcohol under steady-state conditions (kss) at pH 7.5 are given for compari-
son.
VAO variant kobs1 kobs2 kss
s1
pH 7.5
Wild Type 27 1 (0.67) 3.5 0.1 (0.33) 2.4
Y108F 0.061 0.002 (0.17) 0.023 0.001 (0.83) 0.024
Y503F 0.075 0.001 (0.26) 0.025 0.001 (0.74) 0.037
Y108F/Y503F NDa ND 0.01
pH 6.2
Wild Type 35 1 (0.23) 2.9 0.1 (0.77)
Y108F 0.27 0.01 (0.03) 0.0085 0.0001 (0.97)
Y503F 0.33 0.01 (0.03) 0.018 0.001 (0.97)
Y108F/Y503F ND ND
a ND, not determined due to low reaction rate.
Substrate activation in VAO














has taken place (6). Intermediate spectra obtained upon spec-
tral deconvolution of the stopped-flow data are shown in Fig. 3.
The data were fit to a three-phase consecutive model, yielding
four distinct spectral intermediates. Species 1 represents the
oxidized enzyme. Species 3 displays the highest absorption at
373 nm and complete loss of the characteristic oxidized flavin
spectrum. It likely represents the quinone methide-reduced
enzyme complex. Species 2 displays incomplete formation of
the quinone methide intermediate as indicated by its lower
absorption at 373 nm. In addition, part of the FAD cofactor is
still in its oxidized form in this species, as evidenced by the
absorption in the range 440–500 nm. The spectra of species 1,
2, and 3 display an isosbestic point at 423 nm and a spectrum
calculated by assuming that the spectrum of species 2 is a sim-
ple composite of those of species 1 (20%) and 3 (80%) was vir-
tually indistinguishable from the actual spectrum of species 2.
This is consistentwith species 2 not representing a real reaction
intermediate, but rather reflecting the fact that there are two
separate rates of conversion of species 1 to species 3. Species 4
displays a spectrum that is typical of a reduced flavoprotein,
suggesting that this species is formed by the breakdown of the
quinonemethide intermediate by its reaction with water, yield-
ing the product coumaryl alcohol. Thus, the anaerobic reduc-
tion of wt-VAO by chavicol proceeds as follows. First, the sub-
strate binds to the enzyme. Subsequently, the FAD cofactor is
reduced by the substrate leading to the formation of a quinone
methide-reduced enzyme complexwith two kinetic phases that
both contribute to this reduction being distinguished. Follow-
ing reduction, the quinone methide intermediate reacts with
water to yield coumaryl alcohol. Rate constants for these pro-
cesses were obtained by fitting curves of the absorption at 440
nm to a triphasic exponential function. Rate constants for the
two reduction rates (kobs1 and kobs2) are given inTable 3. kobs2 is
similar to the steady-state reaction rate, suggesting it is rate-
limiting for catalysis. The observed rate of decay of the quinone
methide intermediate, kobs3, was similar for all variants (0.1–0.2
s1) and is too slow to be catalytically relevant. Presumably,
breakdown of this intermediate is faster in the presence of oxy-
gen, as has been observed previously for the quinone methide
intermediate formed upon reduction of wt-VAO by 4-(me-
thoxymethyl)phenol (6).
Upon reduction of theY108F andY503F variants by chavicol,
the spectral changes observed were similar to those seen with
wt-VAO, with reduction of FAD occurring concomitantly with
the appearance of a putative quinone methide intermediate
(Fig. 3). The absorption maximum of this intermediate is
shifted to lower wavelengths in the variants (363 nm for Y108F
and 368 nm for Y503F) compared with wt-VAO (373 nm).
Figure 3. Spectral changes observed during the anaerobic reduction of VAO variants by chavicol. Top panels show spectra obtained after mixing 10M
wt-VAO, Y108F, or Y503Fwith 100M chavicol in a stopped-flow apparatus under anaerobic conditions in 50mMpotassiumphosphate buffer, pH 7.5, at 25 °C.
Initially, FAD is reduced and a complex between the reduced enzyme and a para-quinone methide intermediate is formed (solid lines). Subsequently, the
para-quinonemethide intermediate decays, likely due to it reactingwithwater to yield the product (coumaryl alcohol) and the reduced enzyme (dashed lines).
Forwt-VAO, spectrawereobtained0.001, 0.004, 0.009, 0.019, 0.079, 0.60, 2.3, 4.3, 7.2, 12, 25, and75 saftermixing. ForY108F, spectrawereobtained0.001, 0.071,
0.17, 0.31, 0.64, 1.1, 2.2, 6.1, 12, 20, 45, and 120 s after mixing. For Y503F, spectra were obtained 0.001, 0.071, 0.17, 0.31, 0.64, 1.1, 5.0, 8.7, 17, 44, and 120 s after
mixing. Bottom panels show spectra of reaction intermediates obtained after spectral deconvolution of the stopped-flow data for wt-VAO, Y108F, and Y503F.
Datawere fit to a three-phasemodel (1323334), yielding four spectrally distinct species: 1 (O), 2 (- - -), 3 (---), and 4 (). One- or two-phasemodelswere not
able to satisfactorily explain thedata. The rates obtained for the threephases (averageof at least 3measurements) are: k1134 s
1, k23.7 s
1, and k30.093
s1 for wt-VAO, k1 29 s
1, k2 1.7 s
1, and k3 0.051 s
1 for Y108F, and k1 13 s
1, k2 2.7 s
1, and k3 0.083 s
1 for Y503F. These rates are in good
agreement with those obtained by fitting to single wavelength traces at 440 nm (see Table 3).
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Maximum abundance of the intermediate was observed after
2.2 s for the Y108F variant and after 1.5 s for the Y503F variant,
after which the intermediate decays. Spectral deconvolution
again revealed a three-phase process (Fig. 3). As with wt-VAO,
species 1 and 3 represent the oxidized enzyme and the quinone
methide-reduced enzyme complex, respectively. Species 2
again displays an absorption spectrum that is a composite of
that of species 1 and 3 and is likely not a real reaction interme-
diate. Species 4 appears to represent a mixture of quinone
methide-reduced enzyme complex and free reduced enzyme.
This is likely due to the decay of the quinonemethide not being
complete at the end of themeasurement (120 s). Fitting the data
at 440 nm to triple exponential functions revealed that kobs1 and
kobs2 are both decreased in each variant (Table 3). However,
neither rate in either variant decreased more than 10-fold.
Thus, the effect of the Y108F and Y503F mutations on the rate
of reduction of VAO by chavicol is less severe than that on the
reduction by vanillyl alcohol (kobs1 and kobs2 decreased 100-
fold in each variant). Interestingly, a similar effect on the rela-
tive contributions of kobs1 and kobs2 to reduction was observed
with chavicol as with vanillyl alcohol, with kobs1 contributing
most in wt-VAO, but kobs2 contributing most in the Y108F and
Y503F variants. Reduction of the Y108F/Y503F variant by
chavicol was monitored using single wavelength detection at
439 nm. In this case, the data fit best to a double exponential
function. Interestingly, kobs1 is in the same range as for the
Y108F and Y503F variants, whereas kobs2 is an order of magni-
tude smaller. This brings it into the same range as kobs3
observed for wt-VAO and the Y108F and Y503F variants. This
provides an explanation for the absence of a third phase, as
the decay of the quinone methide intermediate is now likely
no longer distinguishable from the second flavin reduction
phase. As with Y108F and Y503F, kobs2 makes the largest
contribution to flavin reduction. For all variants, kobs2 lies
close to the observed rate of steady-state catalysis, suggest-
ing it is rate-limiting.
Upon reduction of wt-VAO and the Y108F and Y503F vari-
ants by 100Mchavicol at pH 6.2, similar spectral changeswere
observed as at pH 7.5. Formation of a quinone methide inter-
mediate and concomitant reduction of FAD were followed by
the decay of the quinone methide intermediate, which was too
slow to be catalytically relevant. The observed reduction rates
are given in Table 3. For wt-VAO, the reduction is a biphasic
process. The two rates are similar to those observed at pH 7.5,
however, as with vanillyl alcohol, the contribution of the rates
to the drop in absorbance changes, with kobs2 becoming more
predominant (a1:a2 1:2 at pH 6.2 compared with a1:a2 3:1
at pH 7.5). For the Y108F and Y503F variants, only a single
reductive phase was observed, with rate constants that are sim-
ilar to those of kobs2 at pH 7.5, suggesting that the observed rate
can be attributed to the same process as kobs2 and that the pro-
cess associated with kobs1 does not make an observable contri-
bution to the reduction at pH6.2. For the Y108F/Y503F variant,
the reduction was observed to be biphasic with the rates of the
two phases and their relative contributions being similar to
those observed at pH 7.5. However, the contribution of the
slower phase to the reduction may be underestimated. After
reduction of Y108F/Y503F a residual absorbance of 0.03 was
measured (usually0.015).With theY108F andY503F variants
it was observed that after the reduction was complete the
absorption at 440 nm increased, likely due to the formation of a
charge-transfer interaction between the reduced enzyme and a
bound substrate molecule. Due to the slow rate of reduction of
the Y108F/Y503F variant, formation of such a charge-transfer
complex could occur on a similar time scale as the reduction,
which would cause part of the absorbance drop associated with
the reduction to be masked.
To study the pH dependence of the reaction in more detail,
the anaerobic reduction of wt-VAO by 50 M chavicol was
studied in the pH range 6.1–9.5. The overall spectral changes,
as monitored using photodiode array detection, were similar to
those observed during the experiments presented in Fig. 3 at all
pH values. Reduction of FAD and concomitant formation of a
quinone methide-reduced enzyme complex was followed by
the decay of the quinonemethide intermediate to yield the fully
reduced enzyme spectrum. As before, the absorption at 440 nm
was fit to a triphasic exponential function, yielding two rates
that are associated with flavin reduction: kobs1 and kobs2. The
values of kobs1 and kobs2 remained similar in this pH range, with
the lowest and highest values never differingmore than a factor
2 (Fig. 4, inset). The pH dependence of the fractional contribu-
tion of kobs1 to the reduction is shown in Fig. 4. The contribu-
tion of kobs1 increases with pH. Attempts to fit the data to the
Henderson-Hasselbach equation, which allows the determina-
tion of the pKa of an ionizable group were unsuccessful.
Although the data display a sigmoidal form, the slope of the
sigmoid is lower than described by the Henderson-Hasselbach
equation. To estimate the midpoint at which the contribution
of kobs1 and kobs2 to reduction is equal, the data were fit to a
sigmoidal curve with the slope as a variable, yielding amidpoint
of pH 6.9.
Isoeugenol-binding studies
To evaluate whether the introduced mutations affect the
protonation state of phenolic compounds bound to VAO, we
studied the binding of the competitive inhibitor isoeugenol to
Table 3
Observed rates of reduction of VAO variants by 100M chavicol
Rates were determined by fitting appropriate exponential functions to traces of the
absorption at 440 nm (from photodiode array detection (wt-VAO, Y108F, and
Y503F)) or 439 nm (from single wavelength detection (Y108F/Y503F)) obtained
after mixing 10 M enzyme with 100 M chavicol in 50 mM potassium phosphate
buffer, pH 6.2 or 7.5, under anaerobic conditions at 25 °C using a stopped-flow
apparatus. Values in parentheses give the relative contribution of kobs1 and kobs2, the
two phases associatedwith flavin reduction, to the drop in absorption. The observed
rates for the oxidation of 100 M chavicol under steady-state conditions (kss) at pH
7.5 are given for comparison.
VAO variant kobs1 kobs2 kss
s1
pH 7.5
Wild Type 139 1 (0.76) 4.5 0.1 (0.24) 6.8
Y108F 33 1 (0.13) 1.6 0.1 (0.87) 2.0
Y503F 14 1 (0.07) 2.6 0.1 (0.93) 2.3
Y108F/Y503F 19 1 (0.05) 0.11 0.01 (0.95) 0.069
pH 6.2
Wild Type 132 1 (0.30) 3.7 0.1 (0.70)
Y108F NOa 0.79 0.01 (1.00)
Y503F NO 1.7 0.1 (1.00)
Y108F/Y503F 21 1 (0.06) 0.027 0.001 (0.94)
a NO, not observed.
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the VAO variants. In solution, the phenolic hydroxyl group of
isoeugenol has a pKa of 10 and its absorption spectrum is
dependent on its protonation state (2). In particular, deproto-
nated isoeugenol displays significantly higher absorption at 320
nm than protonated isoeugenol (320 0.21 mM1 cm1 at pH
6 and 8.8 mM1 cm1 at pH 12). Therefore, the absorption of
isoeugenol at 320 nm upon binding to VAO can act as a
reporter on its protonation state. The pKa of isoeugenol bound
to wt-VAO is 5 (2). To evaluate whether this has been per-
turbed by the introduced mutations, the VAO variants were
titrated with isoeugenol at pH 7.5. At this pH, isoeugenol is
almost entirely protonated in solution, but almost entirely
deprotonated when bound to wt-VAO.
Spectral changes observed upon titration of wt-VAO with
isoeugenol are shown in Fig. 5. Upon addition of isoeugenol, the
intensity of the absorption peak of oxidized FAD at 439 nm
decreases, whereas the absorption at wavelengths below 335
nm increases, which is due to the absorption of the added
isoeugenol. Plots of the absorption at 439 and 320 nm against
the concentration of isoeugenol displayed a curvature indica-
tive of a binding event (Fig. 5, inset). The data at each of these
wavelengths could be satisfactorily fit to a model assuming a
simple 1:1 complex formation between isoeugenol and VAO.
This yielded a dissociation constant of 6.8  0.5 M from the
data at 439 nm and 6.8 1.0 M from the data at 320 nm. The
increase in the absorption at 320 nm associated with binding of
isoeugenol toVAO is indicative of the fact that, as expected, it is
primarily in its deprotonated formupon binding to the enzyme.
Somewhat different spectral changes were observed upon
titration of the Y108F variant with isoeugenol (Fig. 5). As with
wt-VAO, the intensity of the peak at 439 nm decreases and
absorption below 335 nm increases. In addition, a broad
absorption band appears at wavelengths between 500 and 680
nm. Such a broad absorption band at high wavelengths is indic-
ative of a charge-transfer interaction between isoeugenol and
FAD, likely caused by -stacking of the aromatic rings of
isoeugenol and isoalloxazine. Similar charge-transfer bands
have been observed upon binding of various aromatic com-
pounds to the flavoprotein subunit of PCMH (12). Fitting of the
data at 439 nm yielded a dissociation constant of 18  2 M,
suggesting binding of isoeugenol is slightly impaired in the
Y108F variant as compared with wt-VAO. The absorption at
550 nm also displayed curvature indicative of a single binding
event and fitting yielded a dissociation constant of 20  1 M.
This suggests that the drop in absorption at 439 nmand charge-
transfer band at wavelengths above 500 nm are both caused by
the same binding event, the formation of a 1:1 complex between
isoeugenol and Y108F. The absorption at 320 nm, however, did
not display the major increase associated with binding to wt-
VAO. This suggests that isoeugenol is primarily in its proto-
nated formwhen bound to Y108F and that the protonated form
of isoeugenol forms a charge-transfer complex with the FAD
cofactor of Y108F.
For Y503F, the absorption peak at 439 nm also decreased in
intensity upon addition of isoeugenol (Fig. 5). Fitting to the data
at 439 nm yielded a dissociation constant of 91  7 M, indi-
cating that binding of isoeugenol is significantlyweaker than for
wt-VAO. Similar to Y108F, the appearance of a charge-transfer
band at wavelengths above 500 nmwas observed. However, the
measured absorption of this band was too low to reliably deter-
mine the dissociation constant. The absorption at 320 nm
essentially increased linearly with the isoeugenol concentra-
tion, suggesting it is due to the presence of deprotonated
isoeugenol in solution and that isoeugenol is predominantly in
its protonated form upon binding to Y503F.
With Y108F/Y503F, the results of the titration strongly
resemble those with Y108F (Fig. 5). Dissociation constants of
11 1 and 7.0 0.4 M were obtained by fitting to the data at
439 and 550 nm, respectively. The appearance of a charge-
transfer band is observed and the absorption at 320 nmdoes not
show the large increase associated with binding to wt-VAO.
This suggests that, like for the Y108F and Y503F variants,
isoeugenol is predominantly in its protonated form when in
complex with Y108F/Y503F.
Crystal structures
To evaluate the effects of the mutations on the architecture
of the active site ofVAO, the crystal structures of theY108F and
Y503F variants were solved at 2.8-Å resolution, by molecular
replacement using the VAOmonomer (PDB code 2VAO) (4) as
a search model. Attempts to solve the structure of the Y108F/
Y503F variant were hampered by fragility of the crystals. The
overall structures of bothY108F andY503F are essentially iden-
tical to that of wt-VAO, as indicated by an r.m.s. deviation of 0.5
Å for 1105 and 1108 pairs of C atoms, respectively. The asym-
metric unit contains twomonomers, which form the functional
octamer through crystallographic symmetry, as in wt-VAO.
The geometry of the active site in the mutated enzymes is
largely conserved,with the aromatic ring of Phe-108 or Phe-503
located at the same position as the corresponding tyrosine res-
idue in wt-VAO, where they each form a hydrogen bond with
the phenolic hydroxyl group of isoeugenol (Fig. 2) (4). Addi-
tionally, Tyr-108 interacts with Ser-426 via a hydrogen bond.
This interaction is disrupted in the Y108F variant, causing a
Figure 4. pH dependence of the contribution of kobs1 to the reduction of
10 M wt-VAO by 50 M chavicol. Anaerobic substrate and enzyme solu-
tions in Britt-Robinson buffers of appropriate pH values were mixed in a
stopped-flow apparatus and absorbance changes were monitored using a
photodiode array detector. Fitting curves to the absorbance at 440 nm
yielded two reduction rates: kobs1 (fast) and kobs2 (slow). The graph shows the
fraction of the drop in absorbance associated with reduction that is contrib-
uted by kobs1 (fraction kobs1 aobs1/(aobs1	aobs2), where a is the amplitude).
The solid line is a fit of a sigmoidal function to the data, fromwhich amidpoint
pH value (fraction kobs1 fraction kobs2 0.5) of 6.9 was estimated. The inset
shows the values of kobs1 (Œ) and kobs2 (F). The error on each data point is less
than 5%.
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shift of the Phe-108 side chain toward the FAD cofactor (Fig.
2B). In the Y503F variant, the plane of the aromatic ring of
Phe-503 is slightly tilted compared with Tyr-503 in wt-VAO
(Fig. 2C). This may partly be due to the lack of the hydrogen
bond between Tyr-503 and Arg-504 that is present in wt-VAO.
In summary, both overall structures of the Y108F and Y503F
variants and the geometry of their active sites are extremely
similar to wt-VAO. Therefore, changes in reactivity are not due
to major structural perturbations, but can be attributed to dis-
ruption of the hydrogen bonding capacity conferred by the two
tyrosine residues.
Conservation of the phenolate-binding pocket in VAO
homologues
To determine whether the residues that form the phenolate-
binding pocket in VAO are also present in homologous pro-
teins, we evaluated their conservation in a group of homologues
of VAO, EUGO, PCMH, and the related flavocytochrome euge-
nol hydroxylase from Pseudomonas sp. OPS1 (13) that we iden-
tified in a previous study and named the 4-phenol oxidizing
(4PO) subfamily (14). Additionally, we determined whether
they are present in the decarboxylases CndG and FeeG, which
catalyze the oxidative decarboxylation of N-substituted tyro-
sine derivatives (15, 16). These enzymes display homology to
4PO subfamilymembers and catalysis is believed to proceed via
a mechanism whereby the initial formation of a para-quinone
methide intermediate is followed by the expulsion of carbon
dioxide. This analysis revealed that Tyr-108, Tyr-503, and Arg-
504 are strictly conserved suggesting they are of importance for
catalysis in these related enzymes.
Discussion
Our results demonstrate that the presence of at least one of
the active site tyrosine residues, Tyr-108 or Tyr-503, is essential
for efficient catalysis by VAO, with the kcat values for Y108F/
Y503F being less than 2% of those for wt-VAO for each tested
substrate. The effect of the single tyrosine to phenylalanine
mutations on catalytic efficiency was dependent on the sub-
strate. The oxidation of vanillyl alcohol was severely impaired
in both the Y108F and Y503F variants, whereas the oxidation of
chavicol was only slightly impaired as compared with wt-VAO.
Stopped-flow kinetics revealed that reduction of the FAD
cofactor of VAO by vanillyl alcohol or chavicol proceeds at two
distinct rates: kobs1 (fast) and kobs2 (slow). kobs2 lies close to the
rate of steady-state catalysis and, therefore, is probably rate-
limiting. The observed reduction in the rate of steady-state
catalysis for the tyrosine to phenylalanine variants corresponds
with the observed reduction in kobs2, demonstrating that
impaired flavin reduction is the cause of the reduced rate of
catalysis. Titration with the competitive inhibitor isoeugenol
indicated that, at pH 7.5, this molecule is predominantly in its
deprotonated phenolate anion form when bound to wt-VAO,
but predominantly in its protonated form when bound to
Y108F, Y503F, or Y108F/Y503F. In combination, these results
Figure 5. Spectral changes observed upon titration ofwt-VAO, Y108F, Y503F, or Y108F/Y503Fwith the competitive inhibitor isoeugenol. Isoeugenol
was added to a 10 M enzyme solution in 50 mM potassium phosphate buffer, pH 7.5. After each addition, an absorption spectrum was recorded. Spectra
recorded at an isoeugenol concentration of 6.6, 13.2, 19.8, 36.0, 51.9, 98.3, 211, and 312M are shown. The displayed spectra are corrected for dilution due to
the addition of isoeugenol. Arrows indicate the direction of the observed changes in absorption upon increasing isoeugenol concentration. Insets show the
absorptionmeasured at 320 (Œ), 439 (F), and 550 (f) nm, with fitted lines used to determine dissociation constants. Absorbance values in these insets are not
corrected for dilution.
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suggest that Tyr-108 and Tyr-503 play a role in activating the
substrates of VAO for their reaction with its FAD cofactor by
enabling their deprotonation in the active site of the enzyme.
Interestingly, the relative contributions of the two reduction
rates, kobs1 and kobs2, to the change in absorption associated
with flavin reduction changes upon the introduction of the
tyrosine to phenylalanine mutations. At pH 7.5, kobs1 contrib-
utes more to the drop in absorption in wt-VAO, whereas in the
Y108F, Y503F, and Y108F/Y503F variants, kobs2 contributes
more to the drop in absorption. The relative contributions of
the two rates shift when the reduction is performed at pH 6.2,
with the relative contribution of kobs2 becoming greater. The
reduction of the Y108F/Y503F variant by chavicol was an
exception to this observation. However, this may be due to the
contribution of kobs2 to the reduction at pH 6.2 being underes-
timated due to the concomitant formation of a charge-transfer
interaction between the reduced enzyme and substrate. For the
reduction of wt-VAO by chavicol, the contribution of kobs1
increases with pH in the pH range 6.1–9.5. The data were fit to
a sigmoidal curve with a midpoint pH, at which kobs1 and kobs2
contribute equally to the reduction, of 6.9.
Based on these results, we propose a somewhat modified
model for the reaction mechanism of VAO (Fig. 6). Substrates
can bind in the active site of VAO with their phenolic hydroxyl
group either in its protonated or deprotonated form. The affin-
ity of the enzyme for the substrate depends on the protonation
state of the substrate, with wt-VAO displaying a higher affinity
for deprotonated substrates. Subsequently, the substrate reacts
with VAO, a reaction that occurs at different rates depending
on the protonation state of the substrate. With the deproto-
nated substrate, the reaction simply involves the transfer of a
hydride anion to the FAD cofactor to yield the para-quinone
methide intermediate. Reaction with the protonated substrate
requires the deprotonation of the phenolic hydroxyl group of
the substrate either prior to or at the same time as the hydride-
transfer reaction. The proton is transferred to either Tyr-108 or
Tyr-503, which may be transiently deprotonated in the active
site of the enzyme. This is stimulated byArg-504, which is posi-
tioned so as to form a cation- interaction with Tyr-108, low-
ering its pKa. This model explains the two rates of flavin reduc-
tion observed for each substrate, with kobs1 representing the
reaction with deprotonated substrate and kobs2 representing
the reactionwith protonated substrate. This is supported by the
fact that the contribution of kobs1 to flavin reduction increases
with pH, as at higher pH values a larger percentage of the sub-
strate is in its deprotonated form. The results of the isoeugenol
titrations support the idea that substrates bind to Y108F,
Y503F, and Y108F/Y503F predominantly in their protonated
form at pH 7.5, as opposed to wt-VAO where it predominantly
binds in its deprotonated form. This explains the change in the
relative contributions of kobs1 and kobs2 to flavin reduction upon
introduction of the tyrosine to phenylalanine mutations. The
mutations prevent the preferential binding of the deprotonated
form of the substrates observed with wt-VAO due to the loss of
hydrogen-bonding interactions that stabilize the negative
charge on the phenolate oxygen. In support of this, the crystal-
lographic analysis revealed that, although the mutations do not
produce any major structural perturbation of the active site
architecture, they modify the hydrogen-bonding network that
is essential to activate the substrate for the reaction with the
flavin cofactor. The fact that the curve of the fractional contri-
bution of kobs1 to the reduction versus pH does not obey the
Henderson-Hasselbach equation may be attributable to the
effects of functional groups near the phenolic hydroxyl group
on its protonation state, which can have a distorting effect on
the titration behavior of ionizable groups in proteins (17). Addi-
tionally, interconversion of the enzyme-protonated substrate
(Eox–SH) and enzyme-deprotonated substrate (Eox–S) com-
plexes may involve more significant changes than simply the
deprotonation of the phenolic hydroxyl group of the substrate.
The fact that a charge-transfer interaction is observed between
the enzyme and protonated isoeugenol during titrations with
this molecule, but not between the enzyme and deprotonated
isoeugenol, suggest that the ligandmay bind to the enzyme in a
slightly different conformation depending on its protonation
state. Thus conversion of the Eox–SH complex to the Eox–S
complexmay require a reorientation of the substrate within the
active site, and possibly minor changes in the conformation of
active site residues. This could explain the reasonably low rates
observed for kobs2. Although in our view this model provides
the most satisfactory explanation of our observations, an alter-
native mechanism where the two observed reduction rates
reflect the presence of two forms of the enzyme, one in which
bothTyr-108 andTyr-503 are protonated and one inwhich one
of the two tyrosine residues is deprotonated, cannot be fully
ruled out.
The effect of the single Y108F and Y503F mutations on the
rate of reduction of VAOwas dependent on the substrate used.
With the benzylic alcohol vanillyl alcohol, a far more severe
drop in both kobs1 and kobs2 was observed than with the 4-ally-
phenol chavicol. However, the change in the relative contribu-
tions of kobs1 and kobs2 to flavin reduction is similar. Possibly,
the large effect on the reduction rate seenwith vanillyl alcohol is
due to incorrect positioning of the substrate in the active site of
Y108F and Y503F. Hydrogen bonds between the phenolic
hydroxyl group of the substrate and the two tyrosine residues
may be of importance in maintaining it in the correct orienta-
tion for the hydride-transfer reaction to take place. This effect
may be less important for chavicol than for vanillyl alcohol, as
interactions involving its longer side chainmay lock it into posi-
tion in the active site. In this context, it is interesting to note
Figure 6. Proposed model for the reductive half-reaction of VAO. Sub-
strates can bind to the enzyme with their phenolic hydroxyl group in its pro-
tonated (SH) or deprotonated (S) form. Upon binding of the deprotonated
form, the enzyme is reduced, yielding the reduced enzyme–quinone meth-
ide complex. Reductionbydeprotonated substrate corresponds to kobs1 from
the stopped-flow kinetic experiments presented here. Upon binding of the
protonated form, the substrate must be deprotonated to allow flavin reduc-
tion to occur, i.e. the Eox–SH complex must be converted to the Eox–S
 com-
plex. This corresponds to kobs2 from the stopped-flow kinetic experiments.
After the reduction, the product is released from the reduced enzyme. This
step is too slow to be catalytically relevant, suggesting product release is
faster in the presence of dioxygen.
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that the Km for the oxidation of chavicol by wt-VAO is signifi-
cantly lower than that for the oxidation of vanillyl alcohol, indi-
cating tighter binding of chavicol.
In addition to the 4PO subfamilymembersmentioned above,
a catalytic motif composed of two tyrosine residues has been
proposed to be involved in substrate activation in other
enzymes in which catalysis proceeds through a para-quinone
methide intermediate, such as the cofactor-independent hydro-
xycinnamoyl-CoA hydratase-lyase from Pseudomonas fluore-
scens AN103 (18) and bacterial phenolic acid decarboxylases
(19) (although an alternative mechanism has also been pro-
posed (20, 21)). This suggests that these structurally unrelated
proteins have obtained similarmechanisms for the activation of
the phenolic hydroxyl groups of their substrates through con-
vergent evolution.
Catalytic motifs composed of two tyrosine residues have also
been implicated in substrate activation in a number of enzymes
that catalyze oxidation reactions that do not involve a para-
substituted phenol. They have been proposed to facilitate the
activation of hydroxyl groups for their oxidation to carbonyls in
other oxidoreductases from the VAO/PCMH family, such as
aclacinomycin oxidoreductase from Streptomyces galilaeus
ATCC 31615 (22), Dbv29 from Nonomuraea sp. ATCC 39727
(23), GilR from Streptomyces griseoflavus (24), and the monoli-
gnol oxidoreductase BBE-like protein 15 from Arabidopsis
thaliana (25). These enzymes all belong to the same clade of the
VAO/PCMH family, which primarily contains enzymes with a
bicovalently bound FAD cofactor (26). Despite their homology
with VAO, a sequence and structural alignment of the five pro-
teins demonstrated that the tyrosine pair found in these
enzymes is not equivalent to that found in VAO, suggesting the
motifs evolved separately.
In summary, the results presented here indicate that two
tyrosine residues, Tyr-108 and Tyr-503, are responsible for
activating the phenolic substrates of VAO for oxidation by
facilitating the binding of their deprotonated phenolate form in
the active site, shedding light on the catalytic mechanism of




Vanillyl alcohol and isoeugenol were from Sigma. Chavicol
was from Quest International (Naarden, NL). All other chemi-
cals were from commercial sources and of the purest grade
available.
Cloning, protein expression, and purification
Constructs encoding for the Y108F and Y503F variants were
created by linear whole-plasmid amplification from the pBC11
(27) plasmid using the mutagenic primers CATCTCTATTG-
GAAGGAATTCCGGATTTGGCGGTGCTGCGCC (Y108F)
andATGGATGGGGCGAATTTCGAACCCATCTGGC(Y503F)
(nucleotides in italics are the sites of mutation for introduction
of the tyrosine to phenylalanine mutations, the underlined
nucleotide indicates the site of a silentmutation that introduces
an EcoRI site). After amplification and concomitant ligation,
template DNA was digested using DpnI and the mutagenized
plasmids were transformed into DH5 E. coli. Correct plas-
mids, as confirmed by sequencing, were transformed into BL21
E. coli for protein expression. The construct encoding for the
Y108F/Y503F variantwas created in a similarmanner, using the
plasmid encoding for the Y108F variant as the template for
amplification and the primer for the Y503F variant. All variants
were expressed and purified as described previously for wt-
VAO (14).
Analytical methods
Unless specified otherwise, all experiments were performed
in 50mMpotassiumphosphate buffer, pH7.5. Absorption spec-
tra of purified proteins were recorded using a Hewlett Packard
8453 photodiode array spectrophotometer (Agilent Technolo-
gies, Santa Clara, CA) and enzyme concentrations were deter-
mined using the extinction coefficient of wt-VAO at 439 nm
(439 12,500 M1 cm1 (1)). For trichloroacetic acid precipi-
tations, 5% (w/v) trichloroacetic acid was mixed with 10 M
enzyme and samples were incubated on ice for 30 min. Subse-
quently, the precipitated protein was pelleted by centrifugation
(21,000
 g, 15min, 4 °C), and the presence of FAD in the pellet
or supernatant was judged from its color. The absence of FAD
from the supernatants was confirmed by measuring their
absorption spectra. Analytical gel filtration was performed
using a Superdex 200 HR 10/30 column on an A¨kta pure chro-
matography system (GE Healthcare). Samples of enzyme at a
concentration of 10 M were loaded onto the column and sub-
sequently eluted in 50 mM potassium phosphate buffer, pH 7.5,
containing 150mMpotassium chloride.Molecularmasses were
determined based on a calibration curve of proteins of known
mass. Thermal unfolding of the VAO variants was monitored
by the ThermoFAD method (11) using a MiniOpticon real-
time PCR system (Bio-Rad). Protein solutions at a concentra-
tion of 7 M were subjected to a temperature gradient from 25
to 70 °C and the fluorescence of the FAD cofactor was mea-
sured every 0.5 °C with excitation and emission wavelengths of
485 30 and 625 30 nm, respectively. Thermal midpoints of
unfolding were determined by finding the maximum of the
derivative of the unfolding curves.
Steady-state kinetics
All experimentswere performed at 25 °C in 50mMpotassium
phosphate buffer, pH 7.5. The oxidation of vanillyl alcohol to
vanillin was followed bymonitoring the absorption of the prod-
uct at 340 nm (340  14,000 M1 cm1). The oxidation of
chavicol was followed by monitoring oxygen consumption
using a Hansatech Oxytherm system (Hansatech Instruments,
King’s Lynn, UK). Steady-state kinetic parameters were deter-
mined by fitting the obtained data to the Michaelis-Menten
equation (vanillyl alcohol) using IGOR Pro (Wavemetrics, Lake
Oswego, OR) or to amodified version of theMichaelis-Menten
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where kobs is the measured initial rate, kcat is the turnover
number, Km is the Michaelis constant, Ki is the inhibition
constant for substrate inhibition, and [S] is the substrate
concentration.
Stopped-flow kinetics
The reduction ofVAOvariants by vanillyl alcohol or chavicol
was followed using an SX20 stopped-flow system (Applied Pho-
tophysics, Leatherhead, UK) equipped with a photodiode array
detector or a photomultiplier detector as applicable. Enzyme
and substrate solutions in 50 mM potassium phosphate buffer,
pH 6.2 or 7.5, as appropriate, containing 5 mM glucose were
made anaerobic by first flushing them with nitrogen gas for 10
min and then adding 0.3M glucose oxidase. Subsequently, the
enzyme and substrate solutions were mixed to final concentra-
tions of 10 M enzyme and 2 mM (vanillyl alcohol) or 100 M
(chavicol) substrate and spectral changes were monitored at
25 °C. Rate constants were obtained by global fitting ofmultiple
single wavelength traces to appropriate exponential functions
using IGOR Pro. Spectral deconvolution of multiwavelength
data were performed using Pro-Kineticist (Applied Photophys-
ics). To study the pH dependence of the reduction of wt-VAO
by chavicol in more detail, the reaction was performed at
various pH values in the pH range 6.1–9.5. Experiments were
performed in Britt-Robinson buffers consisting of 40 mM
acetic acid, 40 mM phosphoric acid, and 40 mM boric acid set
to the correct pH using potassium hydroxide. The ionic
strength of the buffers was set to 0.2 M by the addition of
potassium sulfate. Subsequently, enzyme and substrate solu-
tions were made anaerobic as described above, mixed to final
concentrations of 10 M enzyme and 50 M chavicol, and the
reduction was monitored at 25 °C and data were analyzed as
described above.
Isoeugenol-binding studies
Changes in the spectral properties of the VAO variants upon
binding of the competitive inhibitor isoeugenol were moni-
tored using a Cary 4000 spectrophotometer (Agilent Technol-
ogies, Santa Clara, CA). Isoeugenol was titrated to 10 M
enzyme in 50 mM potassium phosphate buffer, pH 7.5, and an
absorption spectrum was recorded after every addition. Disso-
ciation constants were determined by fitting the data at a
specific wavelength to a model assuming formation of a 1:1
enzyme–isoeugenol complex using the following formula with
IGOR Pro,
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Ef 	 Et  EI (Eq. 4)
and
If 	 It  EI (Eq. 5)
with E, EI, and I being themolar extinction coefficients of the
free enzyme, the enzyme-inhibitor complex, and the free inhib-
itor, respectively, [E]f being the concentration of free enzyme,
[EI] the concentration of enzyme-inhibitor complex, [I]f the
concentration of free inhibitor, [E]t the total enzyme concen-
tration, [I]t the total inhibitor concentration, and Kd the disso-
ciation constant.
Crystallization and structure determination
VAO variants were crystallized by the hanging drop vapor
diffusion method. Protein solutions at a concentration of 180–
220 M in 50 mM potassium phosphate buffer, pH 7.5, were
mixed 1:1 (v/v) with a mother liquor containing 6% (w/v)
PEG4000 in 100 mM sodium acetate buffer, pH 4.6, and equili-
brated against the mother liquor at 20 °C. Prior to data collec-
tion, crystals were transferred to a cryoprotectant solution con-
taining 10% (w/v) PEG4000 and 20% (w/v) glycerol in 100 mM
sodium acetate buffer, pH 4.6, and cryo-cooled in liquid nitro-
gen. X-ray diffraction data were collected at the X06DA beam-
line of the Swiss Light Synchrotron in Villigen, Switzerland
(SLS), and at the ID30B beamline of the European Synchrotron
Radiation Facility in Grenoble, France (ESRF). Images were
integrated usingMOSFLM (28) and datawere scaled using pro-
grams of theCCP4 suite (29). Detailed data processing statistics
are shown in Table 4. Structures of VAO mutants were solved
by molecular replacement using PHASER (30) with the
structure of wt-VAO (PDB code 2VAO (4)) devoid of all
ligands and water molecules as a search model. Subse-
quently, structures were refined by alternating refinement
using REFMAC5 (31) and manual model building using
COOT (32). Figures were prepared with CCP4mg (33).
Atomic coordinates and structure factors were deposited in
Table 4
Data collection and refinement statistics
Y108F Y503F
PDB code 5MXJ 5MXU
Space group I4 I4
Resolution (Å) 2.8 2.8
a, b, c (Å) 137.9, 137.9, 132.9 138.0, 138.0, 132.9
Rsyma,b,c (%) 8.7 (67.9) 10.1 (63.8)
CC1/2a,c 0.99 (0.54) 0.99 (0.54)
Completenessb (%) 89.7 (91.9) 91.8 (94.3)
Unique reflections 27138 27846
Multiplicityc 2.3 (2.1) 2.4 (2.4)








Average B value for all atoms (Å2) 52.1 52.6
Rcrystc,d (%) 18.0 (34.2) 17.5 (30.2)
Rfreec,d (%) 25.9 (33.7) 24.9 (37.4)
R.m.s. bond length (Å) 0.01 0.01
R.m.s. bond angles (°) 1.56 1.48
Ramachandran outliers (%) 0 0
a Data processing statistics was based on CC1/2 as described in Refs. 34 and 35.
b Rsym Ii I/Ii, where Ii is the intensity of ith observation and I is the
mean intensity of the reflection.
c Values in parentheses are for reflections in the highest resolution shell.
d Rcryst Fobs Fcalc/Fobs, where Fobs and Fcalc are the observed and calcu-
lated structure factor amplitudes, respectively. Rcryst and Rfree were calculated
using the working and test sets, respectively.
Substrate activation in VAO














the Protein Data Bank under the PDB ID codes 5MXJ
(Y108F-VAO) and 5MXU (Y503F-VAO).
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